Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Transmitted Drug Resistance in Newly Diagnosed, Treatment-Naïve, HIV Type 1-Infected Patients in Hungary.

Áy É, Müller V, Mezei M, Pocskay Á, Koroknai A, Müller D, Győri Z, Marschalkó M, Tóth B, Kárpáti S, Lakatos B, Szlávik J, Takács M, Minárovits J.

J Glob Antimicrob Resist. 2019 Jul 19. pii: S2213-7165(19)30180-8. doi: 10.1016/j.jgar.2019.07.014. [Epub ahead of print]

PMID:
31330377
2.

Truncated oncoproteins of retroviruses and hepatitis B virus: A lesson in contrasts.

Minarovits J, Niller HH.

Infect Genet Evol. 2019 Sep;73:342-357. doi: 10.1016/j.meegid.2019.05.020. Epub 2019 May 29. Review.

PMID:
31152910
3.

Flavonol 7-O-Glucoside Herbacitrin Inhibits HIV-1 Replication through Simultaneous Integrase and Reverse Transcriptase Inhibition.

Áy É, Hunyadi A, Mezei M, Minárovits J, Hohmann J.

Evid Based Complement Alternat Med. 2019 Feb 3;2019:1064793. doi: 10.1155/2019/1064793. eCollection 2019.

4.

Chicken or the Egg: Microbial Alterations in Biopsy Samples of Patients with Oral Potentially Malignant Disorders.

Decsi G, Soki J, Pap B, Dobra G, Harmati M, Kormondi S, Pankotai T, Braunitzer G, Minarovits J, Sonkodi I, Urban E, Nemeth IB, Nagy K, Buzas K.

Pathol Oncol Res. 2019 Jul;25(3):1023-1033. doi: 10.1007/s12253-018-0457-x. Epub 2018 Jul 27.

PMID:
30054809
5.

Prevalence and genotypes of human papillomavirus in saliva and tumor samples of head and neck cancer patients in Hungary.

Hettmann A, Demcsák A, Bach Á, Decsi G, Dencs Á, Pálinkó D, Rovó L, Terhes G, Urbán E, Buzás K, Nagy K, Takács M, Minarovits J.

Infect Genet Evol. 2018 Apr;59:99-106. doi: 10.1016/j.meegid.2018.01.030. Epub 2018 Feb 1.

PMID:
29408738
6.

Pathogenic mechanisms of intracellular bacteria.

Niller HH, Masa R, Venkei A, Mészáros S, Minarovits J.

Curr Opin Infect Dis. 2017 Jun;30(3):309-315. doi: 10.1097/QCO.0000000000000363. Review.

PMID:
28134679
7.

Detection and Phylogenetic Analysis of Torque Teno Virus in Salivary and Tumor Biopsy Samples from Head and Neck Carcinoma Patients.

Hettmann A, Demcsák A, Bach Á, Decsi G, Dencs Á, Pálinkó D, Rovó L, Nagy K, Minarovits J, Takács M.

Intervirology. 2016;59(2):123-129. doi: 10.1159/000452974. Epub 2016 Dec 8.

8.

Current Trends and Alternative Scenarios in EBV Research.

Minarovits J, Niller HH.

Methods Mol Biol. 2017;1532:1-32. Review.

PMID:
27873264
9.

Epigenetic regulatory mechanisms ensure the heritable alterations of cellular states. Introduction.

Minarovits J, Helmut Niller H.

Adv Exp Med Biol. 2016;879:vii-viii. No abstract available.

PMID:
27088148
10.

Patho-epigenetics of Infectious Diseases Caused by Intracellular Bacteria.

Niller HH, Minarovits J.

Adv Exp Med Biol. 2016;879:107-130. doi: 10.1007/978-3-319-24738-0_6. Review.

PMID:
26659266
11.

Epigenetic Dysregulation in Virus-Associated Neoplasms.

Minarovits J, Demcsák A, Banati F, Niller HH.

Adv Exp Med Biol. 2016;879:71-90. doi: 10.1007/978-3-319-24738-0_4. Review.

PMID:
26659264
12.

Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.

Niller HH, Banati F, Salamon D, Minarovits J.

Adv Exp Med Biol. 2016;879:39-69. doi: 10.1007/978-3-319-24738-0_3. Review.

PMID:
26659263
13.

Epigenetic Regulation.

Minarovits J, Banati F, Szenthe K, Niller HH.

Adv Exp Med Biol. 2016;879:1-25. doi: 10.1007/978-3-319-24738-0_1. Review.

PMID:
26659261
14.

Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms.

Niller HH, Ay E, Banati F, Demcsák A, Takacs M, Minarovits J.

Rev Med Virol. 2016 Jan;26(1):57-73. doi: 10.1002/rmv.1864. Epub 2015 Nov 23. Review.

PMID:
26593760
15.

Infectious Agents Associated with Head and Neck Carcinomas.

Hettmann A, Demcsák A, Decsi G, Bach Á, Pálinkó D, Rovó L, Nagy K, Takács M, Minarovits J.

Adv Exp Med Biol. 2016;897:63-80. doi: 10.1007/5584_2015_5005. Review.

PMID:
26563307
16.

Genome sequence of a cluster A13 mycobacteriophage detected in Mycobacterium phlei over a half century ago.

Marton S, Fehér E, Horváth B, Háber K, Somogyi P, Minárovits J, Bányai K.

Arch Virol. 2016 Jan;161(1):209-12. doi: 10.1007/s00705-015-2608-7. Epub 2015 Oct 7.

PMID:
26446886
17.

Epstein-Barr virus-host cell interactions: an epigenetic dialog?

Niller HH, Szenthe K, Minarovits J.

Front Genet. 2014 Oct 21;5:367. doi: 10.3389/fgene.2014.00367. eCollection 2014.

18.

Augmented biogas production from protein-rich substrates and associated metagenomic changes.

Kovács E, Wirth R, Maróti G, Bagi Z, Nagy K, Minárovits J, Rákhely G, Kovács KL.

Bioresour Technol. 2015 Feb;178:254-261. doi: 10.1016/j.biortech.2014.08.111. Epub 2014 Oct 2.

19.

Use of MALDI-TOF/MS for routine detection of cfiA gene-positive Bacteroides fragilis strains.

Fenyvesi VS, Urbán E, Bartha N, Abrók M, Kostrzewa M, Nagy E, Minárovits J, Sóki J.

Int J Antimicrob Agents. 2014 Nov;44(5):474-5. doi: 10.1016/j.ijantimicag.2014.07.010. Epub 2014 Aug 25. No abstract available.

PMID:
25216544
20.

The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.

Rasul E, Salamon D, Nagy N, Leveau B, Banati F, Szenthe K, Koroknai A, Minarovits J, Klein G, Klein E.

PLoS One. 2014 Aug 27;9(8):e106008. doi: 10.1371/journal.pone.0106008. eCollection 2014.

21.

Role of epigenetics in EBV regulation and pathogenesis.

Niller HH, Tarnai Z, Decsi G, Zsedényi A, Bánáti F, Minarovits J.

Future Microbiol. 2014;9(6):747-56. doi: 10.2217/fmb.14.41. Review.

PMID:
25046522
22.

Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.

Németh G, Greff Z, Sipos A, Varga Z, Székely R, Sebestyén M, Jászay Z, Béni S, Nemes Z, Pirat JL, Volle JN, Virieux D, Gyuris Á, Kelemenics K, Ay E, Minarovits J, Szathmary S, Kéri G, Orfi L.

J Med Chem. 2014 May 22;57(10):3939-65. doi: 10.1021/jm401742r. Epub 2014 May 2.

PMID:
24742150
23.

Epigenetics of HIV infection: promising research areas and implications for therapy.

Ay E, Banati F, Mezei M, Bakos A, Niller HH, Buzás K, Minarovits J.

AIDS Rev. 2013 Jul-Sep;15(3):181-8. Review.

PMID:
24002202
24.

The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation.

Szenthe K, Koroknai A, Banati F, Bathori Z, Niller HH, Wolf H, Nagy N, Klein E, Minarovits J, Salamon D.

Biochem Biophys Res Commun. 2013 May 24;435(1):8-15. doi: 10.1016/j.bbrc.2013.03.127. Epub 2013 Apr 10.

PMID:
23583387
25.

The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.

Szenthe K, Koroknai A, Banati F, Bathori Z, Lozsa R, Burgyan J, Wolf H, Salamon D, Nagy K, Niller HH, Minarovits J.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):489-95. doi: 10.1016/j.bbrc.2013.03.022. Epub 2013 Mar 23.

PMID:
23528241
26.

Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro.

Marton A, Vizler C, Kusz E, Temesfoi V, Szathmary Z, Nagy K, Szegletes Z, Varo G, Siklos L, Katona RL, Tubak V, Howard OM, Duda E, Minarovits J, Nagy K, Buzas K.

Immunol Lett. 2012 Nov-Dec;148(1):34-8. doi: 10.1016/j.imlet.2012.07.006. Epub 2012 Aug 8.

PMID:
22898052
27.

HIV‑1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity.

Stanojevic M, Alexiev I, Beshkov D, Gökengin D, Mezei M, Minarovits J, Otelea D, Paraschiv S, Poljak M, Zidovec-Lepej S, Paraskevis D.

AIDS Rev. 2012 Jan-Mar;14(1):28-36. Review.

PMID:
22297502
29.

Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease.

Niller HH, Wolf H, Ay E, Minarovits J.

Adv Exp Med Biol. 2011;711:82-102. Review.

PMID:
21627044
30.

Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.

Mezei M, Ay E, Koroknai A, Tóth R, Balázs A, Bakos A, Gyori Z, Bánáti F, Marschalkó M, Kárpáti S, Minárovits J.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1243-7. doi: 10.1089/AID.2011.0077. Epub 2011 May 9.

PMID:
21453184
31.

Novel, selective CDK9 inhibitors for the treatment of HIV infection.

Németh G, Varga Z, Greff Z, Bencze G, Sipos A, Szántai-Kis C, Baska F, Gyuris A, Kelemenics K, Szathmáry Z, Minárovits J, Kéri G, Orfi L.

Curr Med Chem. 2011;18(3):342-58.

PMID:
21143121
32.

Viral hit and run-oncogenesis: genetic and epigenetic scenarios.

Niller HH, Wolf H, Minarovits J.

Cancer Lett. 2011 Jun 28;305(2):200-17. doi: 10.1016/j.canlet.2010.08.007. Epub 2010 Sep 1. Review.

PMID:
20813452
33.

Epstein-Barr virus: Trigger for autoimmunity?

Kaminski HJ, Minarovits J.

Ann Neurol. 2010 Jun;67(6):697-8. doi: 10.1002/ana.22031. No abstract available.

PMID:
20517931
34.

Epigenetic regulation of latent Epstein-Barr virus promoters.

Takacs M, Banati F, Koroknai A, Segesdi J, Salamon D, Wolf H, Niller HH, Minarovits J.

Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):228-35. doi: 10.1016/j.bbagrm.2009.10.005. Epub 2009 Oct 22. Review.

PMID:
19853674
35.

Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.

Anna L, Holmila R, Kovács K, Gyorffy E, Gyori Z, Segesdi J, Minárovits J, Soltész I, Kostic S, Csekeo A, Husgafvel-Pursiainen K, Schoket B.

Mutagenesis. 2009 Nov;24(6):475-80. doi: 10.1093/mutage/gep031. Epub 2009 Jul 30.

PMID:
19643813
36.

Antiviral activities of extracts of Euphorbia hirta L. against HIV-1, HIV-2 and SIVmac251.

Gyuris A, Szlávik L, Minárovits J, Vasas A, Molnár J, Hohmann J.

In Vivo. 2009 May-Jun;23(3):429-32.

37.

Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.

Niller HH, Wolf H, Minarovits J.

Semin Cancer Biol. 2009 Jun;19(3):158-64. doi: 10.1016/j.semcancer.2009.02.012. Epub 2009 Feb 24. Review.

PMID:
19429479
38.

Epigenetic alterations in neoplasia.

Minarovits J.

Semin Cancer Biol. 2009 Jun;19(3):135. doi: 10.1016/j.semcancer.2009.02.014. Epub 2009 Mar 4. No abstract available.

PMID:
19429475
39.

Microbe-induced epigenetic alterations in host cells: the coming era of patho-epigenetics of microbial infections. A review.

Minárovits J.

Acta Microbiol Immunol Hung. 2009 Mar;56(1):1-19. doi: 10.1556/AMicr.56.2009.1.1. Review.

PMID:
19388554
40.

Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.

Salamon D, Banati F, Koroknai A, Ravasz M, Szenthe K, Bathori Z, Bakos A, Niller HH, Wolf H, Minarovits J.

J Gen Virol. 2009 May;90(Pt 5):1183-9. doi: 10.1099/vir.0.007344-0. Epub 2009 Mar 4.

PMID:
19264589
41.

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer.

Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, Snijders PJ, Meijer CJ, Pineau P, Dejean A, Lloveras B, Capella G, Quer J, Buti M, Esteban JI, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D, Gaidano G, Cigudosa JC, Gomez-Lopez G, Pisano DG, Valencia A, Piris MA, Bosch FX, Cahir-McFarland E, Kieff E, Esteller M.

Genome Res. 2009 Mar;19(3):438-51. doi: 10.1101/gr.083550.108. Epub 2009 Feb 10.

42.

The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.

Takacs M, Segesdi J, Banati F, Koroknai A, Wolf H, Niller HH, Minarovits J.

Mediterr J Hematol Infect Dis. 2009 Nov 15;1(2):e2009012. doi: 10.4084/MJHID.2009.012.

43.

Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus.

Fejer G, Koroknai A, Banati F, Györy I, Salamon D, Wolf H, Niller HH, Minarovits J.

J Gen Virol. 2008 Jun;89(Pt 6):1364-70. doi: 10.1099/vir.0.83594-0.

PMID:
18474551
44.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
45.

Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells.

Szalmás A, Bánáti F, Koroknai A, László B, Fehér E, Salamon D, Gergely L, Minárovits J, Kónya J.

Eur J Cancer. 2008 May;44(7):1030-8. doi: 10.1016/j.ejca.2008.02.046. Epub 2008 Apr 18.

PMID:
18378443
46.

CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus.

Banati F, Koroknai A, Salamon D, Takacs M, Minarovits-Kormuta S, Wolf H, Niller HH, Minarovits J.

FEBS Lett. 2008 Mar 5;582(5):705-9. doi: 10.1016/j.febslet.2008.01.042. Epub 2008 Feb 5.

47.

[Human prion diseases: the Hungarian experience].

Kovács GG, Bakos A, Mitrova E, Minárovits J, László L, Majtényi K.

Ideggyogy Sz. 2007 Nov 30;60(11-12):447-52. Hungarian.

PMID:
18200749
48.

Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells.

Gerle B, Koroknai A, Fejer G, Bakos A, Banati F, Szenthe K, Wolf H, Niller HH, Minarovits J, Salamon D.

J Virol. 2007 Dec;81(23):13242-7. Epub 2007 Sep 26.

49.

High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Bakos A, Banati F, Koroknai A, Takacs M, Salamon D, Minarovits-Kormuta S, Schwarzmann F, Wolf H, Niller HH, Minarovits J.

Virus Genes. 2007 Oct;35(2):195-202. Epub 2007 May 18.

PMID:
17510783
50.

Molecular epidemiology of VIM-4 metallo-beta-lactamase-producing Pseudomonas sp. isolates in Hungary.

Libisch B, Muzslay M, Gacs M, Minárovits J, Knausz M, Watine J, Ternák G, Kenéz E, Kustos I, Rókusz L, Széles K, Balogh B, Füzi M.

Antimicrob Agents Chemother. 2006 Dec;50(12):4220-3. Epub 2006 Sep 25.

Supplemental Content

Loading ...
Support Center